Literature DB >> 10654685

Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up.

S S Kroll1, A Khoo, S E Singletary, F C Ames, B G Wang, G P Reece, M J Miller, G R Evans, G L Robb.   

Abstract

In this study, the records of all patients at the University of Texas M. D. Anderson Cancer Center with T1 or T2 breast cancer who were treated between March of 1986 and November of 1990 with mastectomy followed by immediate breast reconstruction were reviewed for the presence of recurrent disease. Patients with in situ disease were not included. Patients were included in the study if a local recurrence occurred (regardless of the length of follow-up) or if a follow-up of 6 years or longer could be obtained. Patients were grouped according to the use or nonuse of skin-sparing mastectomy, by tumor stage, and by nuclear grade of the tumor. The series included 154 patients, of whom 114 had skin-sparing mastectomies and 40 had nonskin-sparing mastectomies. The local recurrence rate in the skin-sparing mastectomy group was 7.0 percent, whereas in the nonskin-sparing mastectomy group it was 7.5 percent. The sample size in the nonskin-sparing mastectomy group was too small for meaningful statistical analysis, but the data suggest that there is no clinically important difference in recurrence rates between the two groups. We conclude that the use of skin-sparing technique for early breast cancer patients does not significantly increase the risk of tumor recurrence after mastectomy.

Entities:  

Mesh:

Year:  1999        PMID: 10654685     DOI: 10.1097/00006534-199908000-00015

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  40 in total

1.  Trends in autologous breast reconstruction.

Authors:  Grant W Carlson
Journal:  Semin Plast Surg       Date:  2004-05       Impact factor: 2.314

Review 2.  What is the evidence behind conservative mastectomies?

Authors:  Nicola Rocco; Giuseppe Catanuto; Maurizio Bruno Nava
Journal:  Gland Surg       Date:  2015-12

Review 3.  Is there any argument for delayed breast reconstruction after total mastectomy?

Authors:  Michael J Greenall
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

4.  MRI-based quantification of residual fibroglandular tissue of the breast after conservative mastectomies.

Authors:  Ramona Woitek; Georg Pfeiler; Alex Farr; Panagiotis Kapetas; Julia Furtner; Maria Bernathova; Veronika Schöpf; Paola Clauser; Maria A Marino; Katja Pinker; Pascal A Baltzer; Thomas H Helbich
Journal:  Eur J Radiol       Date:  2018-04-26       Impact factor: 3.528

5.  Local recurrence of breast cancer in reconstructed breasts using TRAM flap after skin-sparing mastectomy: clinical and imaging features.

Authors:  Hyunkyung Yoo; Bo Hyun Kim; Hak Hee Kim; Joo Hee Cha; Hee Jung Shin; Taik Jong Lee
Journal:  Eur Radiol       Date:  2014-05-24       Impact factor: 5.315

6.  Skin-reducing Mastectomy with Primary Implant Reconstruction.

Authors:  W Siggelkow; K Lübbe; J Gade; H Kölbl; M Schmidt; D Böhm
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-07       Impact factor: 2.915

7.  Single-Stage Immediate Breast Reconstruction Using Anatomical Silicone-Based Implant and The Hammock Technique of Dermal-Muscle Flap in Large and Ptotic breasts: A Multicenter Study.

Authors:  Mohamed A Ellabban; Ahmed Nawar; Hala Milad; Mohammed G Ellabban
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

Review 8. 

Authors:  Ron B Somogyi; Natalia Ziolkowski; Fahima Osman; Alexandra Ginty; Mitchell Brown
Journal:  Can Fam Physician       Date:  2018-06       Impact factor: 3.275

9.  Outcome of management of local recurrence after immediate transverse rectus abdominis myocutaneous flap breast reconstruction.

Authors:  Taik Jong Lee; Wu Jin Hur; Eun Key Kim; Sei Hyun Ahn
Journal:  Arch Plast Surg       Date:  2012-07-13

Review 10.  Recent advances in the surgical care of breast cancer patients.

Authors:  Alessandra Mascaro; Massimo Farina; Raffaella Gigli; Carlo E Vitelli; Lucio Fortunato
Journal:  World J Surg Oncol       Date:  2010-01-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.